Sun Pharma Advanced Research Company has informed that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company’s Code of Conduct for Prevention of Insider Trading (the CoC), the Trading Window for trading in shares of the Company by Designated Persons (along with their immediate relatives and/or persons with whom they share material financial relationship), will be closed with effect from Sunday, January 01, 2023 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and nine months ending on December 31, 2022. The date of Board Meeting for declaration of the Unaudited Financial Results of the Company for the quarter and nine months ending on December 31, 2022 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.